IRIS
MAZZINI, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.322
NA - Nord America 2.725
AS - Asia 2.307
SA - Sud America 413
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 8.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.629
SG - Singapore 952
IE - Irlanda 853
IT - Italia 593
DE - Germania 454
HK - Hong Kong 423
CN - Cina 403
SE - Svezia 366
BR - Brasile 334
RU - Federazione Russa 259
UA - Ucraina 212
VN - Vietnam 184
FI - Finlandia 135
GB - Regno Unito 102
BJ - Benin 101
KR - Corea 91
FR - Francia 79
IN - India 61
CA - Canada 52
PL - Polonia 41
AT - Austria 39
JP - Giappone 36
NL - Olanda 36
ID - Indonesia 30
CZ - Repubblica Ceca 29
MX - Messico 29
TR - Turchia 29
AR - Argentina 28
BD - Bangladesh 25
IR - Iran 25
BE - Belgio 24
EE - Estonia 24
ZA - Sudafrica 24
ES - Italia 19
LT - Lituania 15
DK - Danimarca 14
EC - Ecuador 13
IQ - Iraq 11
RO - Romania 11
CL - Cile 9
MA - Marocco 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
JO - Giordania 7
CO - Colombia 6
PE - Perù 6
CH - Svizzera 4
GR - Grecia 4
VE - Venezuela 4
AU - Australia 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
PA - Panama 3
RS - Serbia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
GD - Grenada 2
IL - Israele 2
LK - Sri Lanka 2
NP - Nepal 2
PK - Pakistan 2
PS - Palestinian Territory 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
DM - Dominica 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 8.924
Salva come PNG Salva come JPEG
Città #
Dublin 849
Hong Kong 420
Jacksonville 349
Singapore 308
Beijing 251
Ashburn 208
Dearborn 157
Chandler 122
Los Angeles 119
Cotonou 101
Moscow 98
Seoul 91
Munich 75
Lawrence 72
Princeton 72
Novara 71
Wilmington 70
Buffalo 68
Ho Chi Minh City 66
Piemonte 61
San Mateo 50
Ann Arbor 49
Bremen 48
Dallas 48
New York 45
Turin 42
Helsinki 41
Rome 39
São Paulo 38
Boardman 36
Hanoi 34
Milan 34
Mülheim 34
Houston 31
Nuremberg 28
Tokyo 28
Warsaw 26
Brno 24
Strasbourg 24
Frankfurt am Main 23
Redondo Beach 23
Stockholm 21
Vienna 20
Santa Clara 19
Brooklyn 18
Brussels 18
Andover 17
Denver 17
Toronto 17
London 16
Jakarta 15
Orem 15
Phoenix 15
Vercelli 15
Amsterdam 14
Chennai 14
Monmouth Junction 14
Montreal 14
Nanjing 14
Turku 14
Woodbridge 14
Ankara 13
Falkenstein 13
Johannesburg 13
Poplar 13
Zanjan 13
Atlanta 12
Boston 12
Mexico City 12
Rio de Janeiro 12
Seattle 12
The Dalles 12
Chicago 11
Kunming 10
Kocmyrzów 9
Quận Bình Thạnh 9
Tianjin 9
Curitiba 8
Hefei 8
Kocaeli 8
Leawood 8
Ottawa 8
Roubaix 8
Amman 7
Biên Hòa 7
Borgomanero 7
Guarulhos 7
Omegna 7
San Francisco 7
Ardabil 6
Augusta 6
Belo Horizonte 6
Brasília 6
Cassano Magnago 6
Falls Church 6
Norwalk 6
Sacramento 6
Salvador 6
San Jose 6
Waanrode 6
Totale 5.035
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 201
Retrospective observational study on the use of acetyl-L-carnitine in ALS 173
Advances in stem cell therapy for amyotrophic lateral sclerosis 148
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 132
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 120
Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis 116
The First Case of the TARDBP p.G294V Mutation in a Homozygous State: Is a Single Pathogenic Allele Sufficient to Cause ALS? 116
Human neural stem cell transplantation in ALS: initial results from a phase I trial. 113
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine: A Population-Based Study. 113
Coeliac disease mimicking Amyotrophic Lateral Sclerosis. 110
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 107
null 105
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 102
Analysis of the KIFAP3 gene in amyotrophic lateral sclerosis: a multicenter survival study 101
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 101
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways 101
Extensive genetics of ALS: a population-based study in Italy. 97
Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis 96
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 95
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 94
Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis 93
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 93
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 91
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 90
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 90
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 89
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 89
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 87
The multistep hypothesis of ALS revisited: The role of genetic mutations 86
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 85
A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient 84
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 84
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 83
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations 82
Autologous Stem Cells Transplantation in Amyotrophic Lateral Sclerosis: A Phase I Clinical Trial 82
Cognitive impairment across ALS clinical stages in a population-based cohort 82
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 82
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 79
Transplantation of mesenchymal stem cells in ALS. 79
Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study. 78
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 77
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. 76
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 74
A rare case of conjugal amyotrophic lateral sclerosis. 73
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 73
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 72
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 72
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS) 71
C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. 70
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 69
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 69
ATXN-2 CAG repeat expansions are interrupted in ALS patients 69
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 67
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 67
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 67
Authors' response to a letter from Dr. Esquinas. 66
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 65
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 65
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis 65
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 64
Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis 64
High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 64
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 64
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 63
Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population 63
VPS54 genetic analysis in ALS Italian cohort 63
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 62
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 61
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. 61
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 60
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 60
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 60
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 60
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 59
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 58
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 57
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 57
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 57
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 57
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 57
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 57
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 56
No association of DPP6 with amyotrophic lateral sclerosis in an Italian population 55
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 54
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 54
Non-invasive ventilation after surgery in amyotrophic lateral sclerosis 54
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 54
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 53
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 53
MRI imaging and clinical features of sciatic nerve injection injury 51
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 50
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 50
Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. 50
Stem cells therapy for ALS 49
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial 49
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 48
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 48
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 48
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 48
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 48
Totale 7.676
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021296 0 0 0 0 0 15 92 18 76 13 74 8
2021/2022594 33 10 57 70 27 10 19 14 46 18 152 138
2022/20231.702 87 84 61 25 112 121 53 81 927 21 92 38
2023/2024644 59 41 78 33 101 20 94 9 11 7 60 131
2024/20252.099 45 44 122 44 39 235 136 212 405 207 171 439
2025/20262.605 327 255 392 844 700 87 0 0 0 0 0 0
Totale 9.172